Texas Biotech (TXB) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Texas Biotech (TXB)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: X. Fang who wrote (537)	1/26/1998 3:06:00 AM
From: Joe Senesac	Read Replies (1) of 834

This is good news, IMHO. Any drug company, if they had more data to submit to support the approval of an application, would do just what TXB did. It is also good that the addition of the data does not seem to change the time frame for possible approval. This is the area where submission of such data could present a snag, but TXB does not seem to think so. That implies that the FDA feels the application is strong on its own merits, that the additional data will simply round out the case for approval. Friday's trading volume was minimal. I don't think the market viewed this as bad at all. It was simply a low volume day that had more sellers than buyers.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next